A. Mathes

发表

Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis

L. Rice, Giuseppina Stifano, R. Christmann, 2014, Arthritis Research & Therapy.

Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor β.

Giuseppina Stifano, R. Lafyatis, R. Christmann, 2013, Arthritis and rheumatism.

Role for toll‐like receptor 3 in muscle regeneration after cardiotoxin injury

R. Lafyatis, A. Mathes, Allison L. Mathes, 2011, Muscle & nerve.

CpGB DNA activates dermal macrophages and specifically recruits inflammatory monocytes into the skin

L. Rice, Giuseppina Stifano, R. Lafyatis, 2015, Experimental dermatology.

Guiding the Killer and Bringing in Accomplices: Bispecific Antibody Treatment for Malignant Melanoma

E. Eaton, R. Christmann, K. Mellody, 2016 .

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

L. Joosten, M. Mayes, J. Reveille, 2014, The New England journal of medicine.

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

M. Whitfield, L. Rice, Jessica Ziemek, 2015, The Journal of clinical investigation.

Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin

T. Radstake, Giuseppina Stifano, T. Radstake, 2013, Annals of the rheumatic diseases.

A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis

M. Whitfield, L. Rice, Giuseppina Stifano, 2015, Arthritis & rheumatology.